BELLICUM PHARMACEUTICALS, INC Annual Return On Assets in % from 2015 to 2022

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Bellicum Pharmaceuticals, Inc quarterly/annual Return On Assets history and growth rate from 2015 to 2022.
  • Bellicum Pharmaceuticals, Inc Return On Assets for the quarter ending September 30, 2023 was -158 %, a 290% decline year-over-year.
  • Bellicum Pharmaceuticals, Inc annual Return On Assets for 2022 was -73.9 %, a 142% decline from 2021.
  • Bellicum Pharmaceuticals, Inc annual Return On Assets for 2021 was -30.6 %, a 168% decline from 2020.
  • Bellicum Pharmaceuticals, Inc annual Return On Assets for 2020 was -11.4 %, a 88.7% increase from 2019.
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2022 -73.9 -43.3 -142% Jan 1, 2022 Dec 31, 2022
2021 -30.6 -19.2 -168% Jan 1, 2021 Dec 31, 2021
2020 -11.4 +89 +88.7% Jan 1, 2020 Dec 31, 2020
2019 -100 -28.4 -39.4% Jan 1, 2019 Dec 31, 2019
2018 -72.1 -14.7 -25.6% Jan 1, 2018 Dec 31, 2018
2017 -57.4 -10.3 -21.9% Jan 1, 2017 Dec 31, 2017
2016 -47.1 -19.4 -70% Jan 1, 2016 Dec 31, 2016
2015 -27.7 Jan 1, 2015 Dec 31, 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.